Yahoo Web Search

Search results

    • American business executive

      • Heather Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company.
      en.wikipedia.org › wiki › Heather_Bresch
  1. People also ask

  2. Heather Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn.

  3. Sep 7, 2021 · Heather Bresch, the former president and CEO of the drugmaker Mylan, worked directly with the CEO of Pfizer to keep prices of the company’s EpiPen product artificially high, according to new...

    • Ryan Grim
  4. As if his own record weren’t bad enough, former coal baron and current West Virginia senator Joe Manchin’s daughter Heather Bresch — who doubles as a major donor to Joe — is a price-gouging drug profiteer who has played a central role in her father’s destructive political career.

  5. Mar 17, 2022 · With a final hearing set for July, the deal puts Heather Bresch, Manchin’s daughter and Mylan’s former CEO, on track to dodge legal repercussion from a yearslong saga involving...

  6. Aug 30, 2023 · Heather Manchin Bresch, 54, became the first woman to run a Fortune 500 pharmaceutical company when she took over the Netherlands-based Mylan in 2012. Bresch and her company were criticized...

    • O'keefe
  7. Nov 20, 2023 · Along with his daughter Heather Bresch, he has been soliciting funds for a new nonprofit that, according to documents reviewed by The Intercept, is being overseen by the senator’s longtime...

  8. Mar 6, 2024 · March 6, 2024. In. Bio. Heather Manchin Bresch, a Dutch pharmaceutical business founded in 1969, was chief executive officer (CEO) of Mylan for some years. She was in charge from 2012 until the firm merged with Pfizer’s Upjohn division in November 2020, at which point she stepped down.

  1. People also search for